Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of https://blakefhno213875.mywikiparty.com/2038489/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment